Paclitaxel is a widely used chemotherapy agent for gynecological cancers, such as ovarian, endometrial, and cervical cancers.
Step 1: Routes of Administration:
1. Intravenous (IV) Administration: The most common route of administration for paclitaxel in gynecological cancers is through IV infusion.
2. Intraperitoneal (IP) Administration: For advanced ovarian cancer, paclitaxel can also be administered intraperitoneally, where it is delivered directly into the peritoneal cavity, allowing for higher local concentrations.
Step 2: Dosing Schedules:
1. Standard Dosing Schedule: Paclitaxel is typically given at a dose of 175 mg/m² IV over 3 hours, every 3 weeks.
2. Weekly Dosing: In some regimens, paclitaxel is given at a lower dose of 80 mg/m² IV weekly for 3 weeks, followed by a week off.
3. Dose Adjustments: Dosing may be adjusted based on the patient's tolerance, especially in the case of hematologic toxicity or neuropathy.
Step 3: Combination Regimens:
Paclitaxel is often used in combination with other chemotherapy drugs such as carboplatin, especially in ovarian cancer.